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Abstract
Objective: To study the management of specific sub-groups
of patients with asthma in Malta, using locally published
guidelines for comparison.
Method: A piloted, structured interview among patients
between the ages of 14-59 years who were hospitalised with an
admission diagnosis of acute asthma. In the case of repeated
admissions, only the first interview was considered. All
interviews were carried out by either of two clinical pharmacists
and lasted about 30 minutes. The four-year prospective study
started in February 1997 (one year before publication of the
Malta guidelines) and finished in January 2001 (three years after
publication).
Main outcome measures:
• Inhaled steroids on admission
• Patient partnership: use of a written self-management plan
and home peak flow monitoring
• Patient compliance with inhaled steroids
Results: 304 patients (68% females; mean population age
33.9 years SD 13.41) were interviewed over the four year period.
Of the 304 patients, 32% were regularly followed up with the
majority of patients (25.3%) being under specialist care; 54%
of patients were not followed up as part of a long-term asthma
management plan. It was not possible to obtain complete
information in 14% of patients. The chi-square test was used to
compare the two groups. With the exception of home peak flow
monitoring, patients who were regularly followed up had
statistically significant better management as recommended by
the Malta asthma guidelines compared to those who were not
regularly followed up.
Conclusion: The findings of this study indicate that regular
physician review results in better asthma management when
assessed by comparison to published guidelines. However,
despite regular follow up, certain aspects of patient care are
inadequate in the light of the Malta asthma guidelines. It is
suggested that the clinical pharmacist is well-placed to offer
advice in order to promote adherence to guidelines.
Introduction
Asthma guidelines have been developed in many countries
in an effort to reduce asthma morbidity and mortality1-9.
Published guidelines recommend regular patient follow-up as
part of a comprehensive long-term asthma management
plan10-12.
The National Heart, Lung and Blood Institute (NHLBI) in
collaboration with World Health Organization has published
guidelines recommending follow-up at one to six monthly
intervals depending upon severity and degree of control10. This
strengthens the partnership between the patient and the
clinician and:
• Ensures that asthma control is maintained
• Ensures that the appropriate step-up or step-down in
treatment is considered
• Gives an opportunity to review and monitor the daily self-
management plans and assess the necessary skills including
use of inhaler device and peak flow meter techniques
• Allows assessment of patient compliance with medication
prescribed
• Provides an opportunity to educate the patient and reinforce
information given during previous visits.
The importance of partnership with the patient through
continuity of care is also emphasized by national guidelines
Antonella Tonna BPharm (Hons), MSc
Department of Pharmacy, St. Luke’s Hospital
Guardamangia, Malta
Email: antonellatonna@hotmail.com
Joseph M Cacciottolo MD, DSc
Department of Medicine, St Luke’s Hospital
Guardamangia, Malta
Email: joseph.cacciottolo@um.edu.mt
Keywords
Malta, asthma, guidelines, adherence, regular follow-up
Malta Medical Journal    Volume 15   Issue 02   November 2003 17
including those published by the British Thoracic Society (BTS)
and the Malta Asthma Guidelines, published in February
199811,12. As described by the authors, the aim of these guidelines
is ‘to optimise long term care of asthma, reduce morbidity and
improve quality of life12.’  Regular patient follow-up is one of
the interventions recommended to achieve this aim. Despite the
fact that the first asthma guidelines were published in 1990 and
despite the importance of regular patient follow up, there are
relatively few studies measuring the impact of regular follow-
up on patient outcomes. A number of published studies and
reviews suggest that discontinuity of care is a risk factor for
adverse asthma outcomes including increased morbidity and
mortality, increased hospitalisation rates and overall caused
suboptimal management of asthma13-16. Patients who are less
likely to receive regular care are the socially disadvantaged, the
poor and ethnic minorities who have less access to medical
care14,15 .   Psychosocial features also need to be considered during
a patient assessment as these have a bearing both on short-term
and long-term management. Studies have indicated that despite
having experienced near fatal asthma, patients still comply
poorly with follow-up care even if this is provided free-of-charge
at regular intervals. Denial is also a  possible reason for non-
compliance17,18.  Patient-physician interaction is another
important determining factor and may result in poor patient
understanding, lack of adherence to prescribed regimens and
an inability to deliver medications correctly.19
The objective of this study is to study the management of
specific sub-groups of patients with asthma in Malta, using
locally published guidelines for comparison.
Method
Study Population
Inclusion criteria were:
• Patients admitted through the Accident and Emergency
(A&E) Department at St. Luke’s Hospital, Malta
• Patients between 14-59 years of age
• Patients with an admission diagnosis of acute severe asthma
made by the admitting medical officer and confirmed by a
more senior physician
• Patients residing in Malta for a minimum of five years.
Exclusion criteria were:
• Patients not falling within the specified age limits
• A referral diagnosis of acute severe asthma not confirmed
on admission by the medical staff at A&E Department
• Newly diagnosed asthmatics or repeat admissions during
the study period
• Individuals on a short visit to Malta
Data collection
A patient interview was considered the most suitable method
to collect data for this study and was preferred to a postal or
self-administered questionnaire since it assured that as many
questions as possible were answered, eliminating any possible
language barrier and any literacy requirements. Precautions
were taken to eliminate interviewer bias. These included
involving the same two interviewers throughout the study years,
involving the interviewers in each stage of development of the
interviewing form and using the exact words and order of
questions on the interviewing form. The questions were mainly
precoded or closed ended questions to allow for easy data
handling.
Development of the interviewing form
An item list of the variables that required to be addressed
was generated following a review and discussion of published
literature relating to the factors associated with hospital
admissions. The following information was utilised for the
purpose of this study:
• General demographic information
• Patient follow up: whether the patient sought medical advice
as part of a prearranged visit to a GP or a respiratory
specialist or only when asthma was out of control
• Appropriateness of use of medication prescribed, including
availability of a spacer device and use and compliance with
inhaled steroid treatment when prescribed
• Patient partnership and involvement in management of the
condition including availability of a self-management plan
and home monitoring
• Assessment of current level of severity of asthma according
to BTS guidelines determined from treatment on admission,
patient’s perception of asthma, number of days per week
the patient is woken up at night due to asthma attacks,
asthma control over the week prior to admission and any
admission to intensive care unit over the previous 5 years.
• Demonstration of inhaler technique: patients were asked
to demonstrate their technique using metered-dose inhalers
with an assessment score based on the recommended close-
mouth technique.19
To ensure clarity of questions, a pilot study was initially car-
ried out when patients were asked to describe what they under-
stood by each question. To validate the interviewing form a test-
retest was performed by conducting the interview on 10 patients
and repeating the interview after four weeks. Inter-rater test-
ing was done by repeating the same interview separately to the
same patient by each of the two interviewers.
Patient recruitment
A&E department admission log books were monitored regu-
larly by pharmacists in the research team between February 1997
and January 2001. Patients’ medical notes were then reviewed
on the ward to confirm the diagnosis and adherence to the in-
clusion criteria. Patients were interviewed within 48 hours of
admission and only the first interview was considered in the
case of readmissions. When comparing the number of patients
recruited to the number of patients with a discharge diagnosis
of asthma as provided by the Department of Health Informa-
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tion, it was estimated that about 80% of patients admitted with
an acute exacerbation of asthma were correctly identified over
the four study years20.
Measures used
Data for the following outcome measures were compared
for patients regularly followed up with those attended to only
when the asthma was out of control:
• Inhaled steroids prescribed prior to admission: this was
determined through the patient interview and confirmed
through the patient’s medical notes or manual records of
medicines dispensed through the government health service
• Patient participation in care: assessed through availability
of a self-management plan and home peak-flow monitoring
• Patient knowledge and understanding assessed by
determining whether the patients maintained the same
doses of inhaled steroids even when asymptomatic and
whether they missed doses of inhaled steroids
• Patient skills: assessed by observing use of inhaler and use
of a spacer device.
Data handling and analysis
Data were coded, entered into Microsoft Excel database and
analysed using SPSS package version 10. Pearson’s chi-square
test (Asymp. Sig, Two-sided) at p<0.01 was used to compare
patients who were regularly followed up with those who were
not regularly followed up. Student’s t-test was used to compare
the average scores for the inhaler technique.
Results
Over the four study years, 398 patients with an admission
diagnosis of an asthma exacerbation were surveyed: 94 patients
did not satisfy the inclusion criteria. Data were incomplete for
43 patients: 29 patients discharged themselves on request, 1
patient passed away, 2 patients suffered from severe disability,
4 patients had severe psychiatric illness and 7 patients were
unwilling to cooperate with the interviewer. There were
approximately twice as many females as males in the study and
the average age was 34 years (Table 1). The average duration of
asthma was 13.6 years with 81 patients suffering from asthma
for less than 5 years and 6 patients suffering from asthma for
more than 46 years.
Table 1: Characteristics of  hospitalised adult asthmatic patients
Year 1 Year 2 Year 3 Year 4 Total
Total number of patients 134 95 84 85 398
Number of newly diagnosed patients 8 7 2 7 24
Number of repeated admissions 13 16 17 24 70
Number of patients eligible for study 113 72 65 54 304
Demographic details for eligible patients
Gender
     Male 42 (37%) 25 (35%) 23 (35%) 18 (33.3%) 108 (35.5%)
     Female 71 (63%) 47 (65%) 42 (65%) 36 (66.7%) 196 (64.5%)
Smoking status
     Nonsmokers 59 (52%) 41 (57%) 37 (57%) 31(57%) 168 (55%)
     Smokers 50 (44%) 26 (36%) 28 (43%) 21 (39%) 125 (41%)
     Unknown 4 (4%) 5 (7%) 2 (4%) 11 (4%)
Average age 33.2 years 33.9 years 33.2 years 34.7 years 33.9 years
±14 ± 12.8 ± 12.6 ± 11.6 ± 13.4
Average years with asthma 19.7 years 17.2 years 12.8 years 13.3 years 13.6 years
± 12.7 ± 15.5 ± 10.1 ± 11.7 ± 11.5
Patient Follow up
     Regularly followed up 39 (34.5%) 24 (33.3%) 18 (27.7%) 16(29.6%) 97 (31.9%)
     Not regularly followed up 71 (62.8%) 41 (56.9%) 36 (55.4%) 16 (29.6%) 164 (53.9%)
     Unknown* 3 (2.7%) 7 (9.8%) 11 (16.9) 22 (40.8%) 43 (14.2%)
*Data were incomplete in the case of 43 patients over the four study years: 29 self-discharged, 7 not cooperative, 4 patients with
psychiatric illness, 2 severely disabled and 1 died.
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Indices of severity of asthma for the patient group are
summarised in Table 2. Descriptive analysis indicates that
patients were suffering mostly from moderate to severe asthma.
Of the 304 patients, 32% were regularly followed up with
6.6% of them followed up by primary care physicians and 25.3%
of patients under specialist care. A majority of patients (54%)
were not followed up as part of a long-term management plan.
The Malta guidelines recommend use of an inhaled steroid as
first-line management in moderate to severe asthma. Most of
the patients in the followed up and regularly reviewed group
(92.8%) were on inhaled steroids prior to admission. In contrast,
fewer patients who had not been regularly followed up were on
inhaled steroids (68.9%) and statistical significance (at p<0.01)
was found when comparing the two groups. Table 3 summarises
data for the outcome measures for the two patient groups.
Management plans recommended in the guidelines indicate
the need to use a spacer device to reduce adverse effects and
maximise the efficacy of inhaled steroids. Statistical significance
was found when comparing the groups with the number of pa-
tients using a spacer being higher in the regularly reviewed
group (69.1%) compared to 37.1% of patients who were not regu-
larly followed up. Patients’ inhaler technique was observed and
the mean score obtained by patients regularly supervised was
5.85 out of 8 (SD1.94) while that obtained by patients who were
not followed up was 5.64 out of 8 (SD1.89). No statistically sig-
nificant difference was found between these two groups. Pa-
tients were asked whether the same dose of inhaled steroid was
maintained even when asymptomatic, with the question being
omitted when the patients were not on an inhaled steroid. Sta-
tistical significance was found between the two groups with
patients not regularly followed up having a greater tendency to
stop the inhaled steroid when they become asymptomatic.
Self-management based on home peak-flow monitoring is
recommended by the Malta guidelines with an Asthma Treat-
ment Card to help in self-management proposed as an annex to
the guidelines. Statistical significance was found when compar-
ing the two groups, again with patients reviewed regularly be-
ing more likely to be provided with a written self-management
plan. There is no significant difference when comparing groups
for availability of a personal peak-flow meter, with only around
10% of patients overall, being in possession of such a device.
Limitations
These include:
• A manual system for recording patients at A&E department
made screening difficult
• Missing out patients admitted to antenatal wards since an
alternative diagnosis to asthma was documented
• Determining patient compliance through interview resulting
in a subjective result
• Not interviewing patients discharged at request. This may
introduce bias towards compliant patients since it is most
likely that those discharged at request also tend to be
noncompliant to health care advice
Table 2: Indices of asthma severity
% number of patients (n=304)
Step in BTS Guidelines
Step 1 17.4
Step 2 42.8
Step 3 21.0
Step 4 7.8
Step 5 0
No treatment 4.5
Not as per guidelines 6.5
Chronic Asthma Severity
Number of nights disturbed due to asthma per week
0 46.0
1 3.0
2 7.3
3 4.3
4 1.8
5 0.3
6 0.7
7 19.4
Data incomplete 17.2
Effect of asthma on daily activities
No effect 24.7
Little 8.9
Moderate 26.6
Severe 25.0
Data incomplete 14.8
ITU admissions in past 5 years
0 82.6
1 2.3
2 0.3
Data incomplete 14.8
Management of exacerbation
Nebulised treatment in prior week
No 30.9
Yes 54.6
Data incomplete 14.5
Oral steroids in prior week
No 56.3
Yes 29.6
Data incomplete 14.1
Discussion
In Malta, this is the first study carried out to compare ac-
tual practice with optimal practice. The number of patients regu-
larly supervised is low when compared to studies in other com-
munities where rates of 83-100% are quoted (compared to the
local rate of 32%)21-24. Often, this has been related to a lack of
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availability of medical treatment. However, this is not the case
locally where both medical supervision and treatment are of-
fered free of charge and are easily accessible to all asthmatics.
This points to the need for better patient education in order to
understand the importance of regular follow-up as part of an
overall management plan. The number of patients followed up
by their family doctor is very low compared to the number of
patients followed up by respiratory specialists. This does not
follow trends reported in the literature where a larger number
of patients are followed up in a primary rather than in a sec-
ondary care setting21-24. This may indicate the need to restruc-
ture primary care particularly with respect to follow-up care
offered at regional health centres. These seem to be utilised
mainly when the condition is out of control rather than as part
of a long-term management plan.
Results of this study are consistent with those of other pub-
lished reports where discontinuity of supervised care has been
linked to unfavourable asthma outcomes13-18. With the excep-
tion of home peak-flow monitoring, all outcomes measured were
significantly different in the patients regularly followed up when
compared to patients who only sought medical help when
asthma was out of control. Such a result supports the hypoth-
esis that regular physician review results in better asthma man-
agement when measured against published guidelines. Several
studies indicate that rate of adherence to guidelines is higher
when patients are followed up by specialists compared to gen-
eral pracitioner follow-up23,25. Comparison of the two groups
was not possible in this study due to the small number of pa-
tients followed up by general practitioners, however further re-
search work in this area is necessary in order to study this fea-
ture.
Adherence to guidelines within the regularly followed up
group has been particularly disappointing in areas related to
patients’ participation in their treatment (88% of patients do
not have a self-management plan, 90% do not own a peak-flow
meter), patient education and compliance with long term in-
haled steroid use (44% of patients kept the same level of in-
haled steroids when they were symptom free). This is consis-
tent with results published in the literature where this area of
patient care is inadequate in meeting published guidelines21-23 .
Further research is needed to determine the reasons for the di-
vergence observed. This could be due to gaps in guideline dis-
semination to physicians, or perhaps due to a lack of patient
education. Patients may also be reluctant to participate in deci-
sion taking. Whatever the reasons, it is clear that much work
needs to be done to promote adherence to the guidelines in or-
der to optimise patient care. Careful planning and the use of
promotional strategies should be adopted. The clinical phar-
Table 3: Summary of the outcome measures when comparing patients followed up regularly with those not followed up
Outcome measure Regularly Not regularly Critical Value Statistical
followed up  followed up Significance
% %
n= 97 n= 164 (p<0.01)
Steroid use on admission 20.1 Yes
No 7.2 31.1
Yes 92.8 68.9
Spacer device availability 24.27 Yes
No 30.9 62.9
Yes 69.1 37.1
Self management plan 7.3 Yes
No 88.7 96.9
Yes 11.3 3.1
Home peak flow monitoring No
No 89.7 96.3
Yes 10.3 3.7
Compliance with inhaled steroids
when asymptomatic 12.2 Yes
Stop treatment 27.9 48.6
Reduce doses 27.9 29
Same doses 44.2 22.4
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macist, as a member of a multidisciplinary team, is very well-
placed to promote the implementation of suggestions and rec-
ommendations found in guidelines for asthma care.
Conclusion
The findings of this study indicate that regular physician
review results in better asthma management when compared
to published guidelines. However, despite regular follow up,
certain aspects of patient care are inadequate when measured
against the Malta asthma management guidelines.
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